VINC

Vincerx Pharma Inc · NASDAQ

Sector Health Technology
Industry Pharmaceuticals: Major
Website vincerx.com
Employees(FY) 41
ISIN US92731L1061

Performance

-18.75%

1W

-26.51%

1M

-61.85%

3M

-4.08%

6M

-41.47%

YTD

-57.89%

1Y

Profile

Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. It is developing enitociclib, a cyclin-dependent kinase-9 inhibitor that is in Phase 1 clinical trials for treating patients with hematologic malignancies; and VIP236, a small molecule drug conjugate that is in Phase 1 clinical trials to treat solid tumors. The company's preclinical stage product candidates include VIP943 and VIP924 for the treatment of hematologic malignancies. Vincerx Pharma, Inc. was founded in 2019 is based in Palo Alto, California.

Advanced Technical Analysis

Technical Analysis of VINC 2024-05-10

Overview:

In analyzing the technical indicators for VINC over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days.

Trend Analysis:

Moving Averages (MA): The 5-day MA has been consistently below the closing price, ind...

See more ...

Recent News & Updates

2024-05-14 09:54
VINC Stock Earnings: Vincerx Pharma Misses EPS for Q1 2024(Investorplace)
2024-05-14 04:15
Vincerx Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update(Globenewswire)
2024-04-26 00:27
Vincerx Pharma Announces Pricing of Underwritten Public Offering of Common Stock and Warrants(Globenewswire)
2024-04-25 18:35
Vincerx Pharma Prices Public Offering of Shares, Warrants(Yahoo Finance)
2024-04-25 04:01
Vincerx Pharma Announces Proposed Underwritten Public Offering of Common Stock and Warrants(Globenewswire)
2024-04-09 01:34
Vincerx (VINC) Tumbles on Results From Cancer Therapy Study(Zacks)
2024-04-09 00:29
Why Is Small-Cap Cancer Focused Vincerx Pharma Stock Plummeting On Tuesday?(Yahoo Finance)
2024-04-08 20:40
Why Is Vincerx Pharma (VINC) Stock Down 64% Today?(Investorplace)
2024-04-08 04:30
Vincerx Pharma Presents Positive Preliminary Phase 1 Data for VIP236 and Updates on Pipeline Progress at the American Association for Cancer Research (AACR) Annual Meeting 2024(Globenewswire)
2024-04-01 19:53
VINC Stock Earnings: Vincerx Pharma Beats EPS for Q4 2023(Investorplace)
2024-03-31 20:00
Vincerx to Host Virtual Investor Event Reviewing Preliminary Phase 1 VIP236 Data Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024(Globenewswire)
2024-03-29 04:51
Vincerx Pharma Inc (VINC) Reports Q4 and Full Year 2023 Financials: A Close Look(Yahoo Finance)
2024-03-29 03:20
Vincerx Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Update(Globenewswire)
2024-03-13 21:38
12 Most Profitable Biotech Stocks To Invest In(Yahoo Finance)
2024-03-13 21:38
12 Most Profitable Biotech Stocks To Invest In(Insidermonkey)
2024-03-05 03:31
Vincerx to Present Three Posters at the American Association for Cancer Research (AACR) Annual Meeting 2024(Globenewswire)
2024-01-07 02:00
Vincerx Pharma Announces Compelling Clinical Efficacy of Enitociclib in Combination with Venetoclax and Prednisone in Lymphoma(Globenewswire)
2023-12-09 23:00
Vincerx Pharma Presents Preclinical VIP943 and VIP924 Posters at ASH 2023(Globenewswire)
2023-11-13 18:00
Vincerx Pharma Reports Third Quarter 2023 Financial Results and Provides Corporate Update(Globenewswire)
2023-11-01 21:10
Vincerx Pharma To Present Three Posters at ASH 2023 in December(Globenewswire)
2023-10-12 21:12
New to The Street Airs Televised Corporate Interviews Episodes 521 and 522 as Sponsored Programming on Bloomberg TV and The Fox Business Network(Globenewswire)
2023-10-05 21:30
New to The Street Announces TV Corporate Appearances, Broadcasting Episode 518 on Newsmax and Episode 519 on FOX Business Network, Airings start on Saturday, October 7, 2023, at 3:30 PM ET(Globenewswire)
2023-09-18 19:00
Vincerx Pharma to Participate at the Cantor Fitzgerald Global Healthcare Conference 2023(Yahoo Finance)
2023-09-13 19:00
Vincerx Pharma Doses First Patient in the Phase 1 Clinical Trial Evaluating VIP943(Yahoo Finance)
2023-08-21 19:30
Vincerx Pharma Announces FDA Clearance of IND for VIP943(Yahoo Finance)
2023-08-06 21:25
Vincerx Pharma Reports Second Quarter 2023 Financial Results and Provides Corporate Update(Yahoo Finance)
2023-05-11 04:05
Vincerx Pharma Reports First Quarter 2023 Financial Results and Provides Corporate Update(Yahoo Finance)
2023-04-18 21:05
Vincerx Pharma Presents Preclinical Data on VIP924, a First-in-Class Antibody-Drug Conjugate (ADC), at the 2023 American Association for Cancer Research (AACR) Annual Meeting(Yahoo Finance)
2023-04-17 01:35
Vincerx Pharma Presents Preclinical Data on Novel Small Molecule Drug Conjugates at the American Association for Cancer Research (AACR) Annual Meeting 2023(Yahoo Finance)
2023-04-16 20:00
Vincerx Pharma Presents Preclinical Data on VIP236, a First-in-Class Small Molecule Drug Conjugate (SMDC), at the 2023 American Association for Cancer Research (AACR) Annual Meeting(Yahoo Finance)

Page 1 of 3

previousnext